The epidemiology of breast cancer
1991; Wiley; Volume: 41; Issue: 3 Linguagem: Inglês
10.3322/canjclin.41.3.146
ISSN1542-4863
AutoresJennifer L. Kelsey, Marilie D. Gammon,
Tópico(s)Breast Cancer Treatment Studies
ResumoCA: A Cancer Journal for CliniciansVolume 41, Issue 3 p. 146-165 ArticleFree Access The epidemiology of breast cancer J. L. Kelsey PhD, J. L. Kelsey PhD Professor of Public Health (Epidemiology) and Head of the Division of Epidemiology at the Columbia University School of Public Health in New York, New YorkSearch for more papers by this authorM. D. Gammon PhD, M. D. Gammon PhD Assistant Professor of Public Health (Epidemiology) at the Columbia University School of Public Health in New York, New YorkSearch for more papers by this author J. L. Kelsey PhD, J. L. Kelsey PhD Professor of Public Health (Epidemiology) and Head of the Division of Epidemiology at the Columbia University School of Public Health in New York, New YorkSearch for more papers by this authorM. D. Gammon PhD, M. D. Gammon PhD Assistant Professor of Public Health (Epidemiology) at the Columbia University School of Public Health in New York, New YorkSearch for more papers by this author First published: May/June 1991 https://doi.org/10.3322/canjclin.41.3.146Citations: 148AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Boring CC, Squires TS, Tong T: Cancer statistics, 1991. CA 41: 19– 36, 1991. 2 American Cancer Society: Cancer Facts & Figures—1991. Atlanta, American Cancer Society, 1991, p9. 3 Ries LAG, Hankey BF, Edwards BK: Cancer Statistics Review 1973–87. NIH Publication No 90-2789. Bethesda, Md, Division of Cancer Prevention and Control, National Cancer Institute, 1990. 4 Berkowitz GS, Kelsey JL: Epidemiology of breast cancer, in DJ Marchant (ed): Diagnosis and Management of Breast Cancer. New York, Elsevier, in press. 5 C Muir, J Waterhouse, T Mack, et al (eds): Cancer on Five Continents, vol 5. IARC Publication No 88. International Agency for Research on Cancer and International Association of Cancer Registries, Lyon, France, 1987. 6 Buell P: Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 51: 1479– 1483, 1973. 7 Miller AB, Bulbrook RD: UICC multidisciplinary project on breast cancer: The epidemiology, aetiology and prevention of breast cancer. Int J Cancer 37: 173– 177, 1986. 8 MacMahon B, Cole P, Lin TM, et al: Age at first birth and breast cancer risk. Bull WHO 43: 209– 221, 1970. 9 Pathak DR, Speizer FE, Willett WC, et al: Parity and breast cancer risk: Possible effect on age at diagnosis. Int J Cancer 37: 21– 25, 1986. 10 Bruzzi P, Negri E, La Vecchia C, et al: Short term increase in risk of breast cancer after full term pregnancy. Br Med J 297: 1096– 1098, 1988. 11 Kvåle G, Heuch I, Eide GE: A prospective study of reproductive factors and breast cancer: I. Parity. Am J Epidemiol 126: 831– 841, 1987. 12 Layde PM, Webster LA, Baughman AL, et al: The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. J Clin Epidemiol 42: 963– 973, 1989. 13 Byers T, Graham S, Rzepka T, et al: Lactation and breast cancer: Evidence for a negative association in premenopausal women. Am J Epidemiol 121: 664– 674, 1985. 14 McTiernan A, Thomas DB: Evidence for a protective effect of lactation on risk of breast cancer in young women: Results from a case-control study. Am J Epidemiol 124: 353– 358, 1986. 15 Siskind V, Schofield F, Rice D, Bain C: Breast cancer and breastfeeding: Results from an Australian case-control study. Am J Epidemiol 130: 229– 236, 1989. 16 Brignone G, Cusimano R, Dardanoni G, et al: A case-control study on breast cancer risk factors in a southern European population. Int J Epidemiol 16: 356– 361, 1987. 17 London SJ, Colditz GA, Stampfer MJ, et al: Lactation and risk of breast cancer in a cohort of US women. Am J Epidemiol 132: 17– 26, 1990. 18 Henderson BE, Ross RK, Judd HL, et al: Do regular ovulatory cycles increase breast cancer risk?. Cancer 56: 1206– 1208, 1985. 19 Irwin KL, Lee NC, Peterson HB, et al: Hysterectomy, tubal sterilization, and the risk of breast cancer. Am J Epidemiol 127: 1192– 1201, 1988. 20 Rosenberg L, Palmer JR, Kaufman DW, et al: Breast cancer in relation to the occurrence and time of induced and spontaneous abortion. Am J Epidemiol 127: 981– 989, 1988. 21 Ewertz M, Duffy SW: Risk of breast cancer in relation to reproductive factors in Denmark. Br J Cancer 58: 99– 104, 1988. 22 Hadjimichael OC, Boyle CA, Meigs JW: Abortion before first livebirth and risk of breast cancer. Br J Cancer 53: 281– 284, 1986. 23 Howe HL, Senie RT, Bzduch H, Herzfeld P: Early abortion and breast cancer risk among women under age 40. Int J Epidemiol 18: 300– 304, 1989. 24 Brinton LA, Melton LJ 3d, Malkasian GD Jr, et al: Cancer risk after evaluation for infertility. Am J Epidemiol 129: 712– 722, 1989. 25 Gammon MD, Thompson WD: Infertility and breast cancer: A population-based case-control study. Am J Epidemiol 132: 708– 716, 1990. 26 Cowan LD, Gordis L, Tonascia JA, Jones GS: Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol 114: 209– 217, 1981. 27 Ron E, Lunenfeld B, Menczer J, et al: Cancer incidence in a cohort of infertile women. Am J Epidemiol 125: 780– 790, 1987. 28 Coulam CB, Annegers JF, Kranz JS: Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 61: 403– 407, 1983. 29 Kvåle G, Heuch I: A prospective study of reproductive factors and breast cancer: II. Age at first birth and last birth. Am J Epidemiol 126: 842– 850, 1987. 30 Trichopoulos D, Hsieh C, MacMahon B, et al: Age at any birth and breast cancer risk. Int J Cancer 31: 701– 704, 1983. 31 Jacobson HI, Thompson WD, Janerich DT: Multiple births and maternal risk of breast cancer. Am J Epidemiol 129: 865– 873, 1989. 32 Thompson WD, Jacobson HI, Negrini B, Janerich DT: Hypertension, pregnancy, and risk of breast cancer. J Natl Cancer Inst 81: 1571– 1574, 1989. 33 Le Marchand L, Kolonel LN, Myers BC, Mi MP: Birth characteristics of premenopausal women with breast cancer. Br J Cancer 57: 437– 439, 1988. 34 Thompson WD, Janerich DT: Maternal age at birth and risk of breast cancer in daughters. Epidemiology 1: 101– 106, 1990. 35 Key TJ, Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29– 43, 1988. 36 de Waard F, Trichopoulos D: A unifying concept of the aetiology of breast cancer. Int J Cancer 41: 666– 669, 1988. 37 L'Hermite M, L'Hermite-Baleriaux M: Prolactin and breast cancer. Eur J Cancer Clin Oncol 24: 955– 958, 1988. 38 Trichopoulos D, Brown J, MacMahon B: Urine estrogens and breast cancer risk factors among post-menopausal women. Int J Cancer 40: 721– 725, 1987. 39 Moore JW, Clark GM, Hoare SA, et al: Binding of oestradiol to blood proteins and aetiology of breast cancer. Int J Cancer 38: 625– 630, 1986. 40 Takatani O, Kosano H, Okumoto T, et al: Distribution of estradiol and percentage of free testosterone in sera of Japanese women: Preoperative breast cancer patients and normal controls. J Natl Cancer Inst 79: 1199– 1204, 1987. 41 Wysowski DK, Comstock GW, Helsing KJ, Lau HL: Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 125: 791– 799, 1987. 42 Secreto G, Toniolo P, Pisani P, et al: Androgens and breast cancer in premenopausal women. Cancer Res 49: 471– 476, 1989. 43 Meyer F, Brown JB, Morrison AS, MacMahon B: Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J Natl Cancer Inst 77: 613– 616, 1986. 44 Thomas BS, Bulbrook RD, Goodman MJ, et al: Thyroid function and the incidence of breast cancer in Hawaiian, British and Japanese women. Int J Cancer 38: 325– 329, 1986. 44a Gordon GB, Bush TL, Helzlsouer KJ, et al: Relationship of serum levels of dehydro-epiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res 50: 3859– 3862, 1990. 45 Kuller LH, Gutai JP: Re: " Sex hormone levels in serum in relation to the development of breast cancer" (letter). Am J Epidemiol 127: 201– 202, 1988. 46 Ernster VL, Wrensch MR, Petrakis NL, et al: Benign and malignant breast disease: Initial study results of serum and breast fluid analyses of endogenous estrogens. J Natl Cancer Inst 79: 949– 960, 1987. 47 Petrakis NL, Wrensch MR, Ernster VL, et al: Influence of pregnancy and lactation on serum and breast fluid estrogen levels: Implications for breast cancer risk. Int J Cancer 40: 587– 591, 1987. 48 Gruenke LD, Wrensch MR, Petrakis NL, et al: Breast fluid cholesterol and cholesterol epoxides: Relationship to breast cancer risk factors and other characteristics. Cancer Res 47: 5483– 5487, 1987. 49 Wrensch MR, Petrakis NL, Gruenke LD, et al: Breast fluid cholesterol and cholesterol beta-epoxide concentrations in women with benign breast disease. Cancer Res 49: 2168– 2174, 1989. 50 Prentice RL, Thomas DB: On the epidemiology of oral contraceptives and disease. Adv Cancer Res 49: 285– 401, 1987. 51 Olsson H, Möller TR, Ranstam J: Early oral contraceptive use and breast cancer among premenopausal women: Final report from a study in southern Sweden. J Natl Cancer Inst 81: 1000– 1004, 1989. 52 Meirik O, Lund E, Adami HO, et al: Oral contraceptive use and breast cancer in young women: A joint national case-control study in Sweden and Norway. Lancet 2: 650– 654, 1986. 53 UK National Case-Control Study Group: Oral contraceptive use and breast cancer risk in young women. Lancet 1: 973– 982, 1989. 54 McPherson K, Vessey MP, Neil A, et al: Early oral contraceptive use and breast cancer: Results of another case-control study. Br J Cancer 56: 653– 660, 1987. 55 Kay CR, Hannaford PC: Breast cancer and the pill—a further report from the Royal College of General Practioners' oral contraception study. Br J Cancer 58: 675– 680, 1988. 56 Yuan JM, Yu MC, Ross RK, et al: Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res 48: 1949– 1953, 1988. 57 Hennekens CH, Speizer FE, Lipnick RJ, et al: A case-control study of oral contraceptive use and breast cancer. J Natl Cancer Inst 72: 39– 42, 1984. 58 Rohan TE, McMichael AJ: Oral contraceptive agents and breast cancer: A population-based case-control study. Med J Aust 149: 520– 526, 1988. 59 Miller DR, Rosenberg L, Kaufman DW, et al: Breast cancer before age 45 and oral contraceptive use: New findings. Am J Epidemiol 129: 269– 280, 1989. 60 Stanford JL, Brinton LA, Hoover RN: Oral contraceptives and breast cancer: Results from an expanded case-control study. Br J Cancer 60: 375– 381, 1989. 61 Stadel BV, Lai SH, Schlesselman JJ, Murray P: Oral contraceptives and premenopausal breast cancer in nulliparous women. Contraception 38: 287– 299, 1988. 62 Jick SS, Walker AM, Stergachis A, Jick H: Oral contraceptives and breast cancer. Br J Cancer 59: 618– 621, 1989. 63 Ravnihar B, Primic Zakelj M, Kosmelj K, Stare J: A case-control study of breast cancer in relation to oral contraceptive use in Slovenia. Neoplasma 35: 109– 121, 1988. 64 Vessey MP, McPherson K, Villard-Mackintosh L, Yeates D: Oral contraceptives and breast cancer: Latest findings in a large cohort study. Br J Cancer 59: 613– 617, 1989. 65 The WHO Collaborative Study of Neoplasia and Steroid Contraceptives: Breast cancer and combined oral contraceptives: Results from a multinational study. Br J Cancer 61: 110– 119, 1990. 66 Stadel BV, Schlesselman JJ: Oral contraceptive use and the risk of breast cancer in women with a " prior" history of benign breast disease. Am J Epidemiol 123: 373– 382, 1986. 67 Lee NC, Rosero-Bixby L, Oberle MW, et al: A case-control study of breast cancer and hormonal contraception in Costa Rica. J Natl Cancer Inst 79: 1247– 1254, 1987. 68 Murray PP, Stadel BV, Schlesselman JJ: Oral contraceptive use in women with a family history of breast cancer. Obstet Gynecol 73: 977– 983, 1989. 69 Romieu I, Willett WC, Colditz GA, et al: Prospective study of oral contraceptive use and risk of breast cancer in women. J Natl Cancer Inst 81: 1313– 1321, 1989. 70 Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development: Oral-contraceptive use and the risk of breast cancer. N Engl J Med 315: 405– 411, 1986. 71 Paul C, Skegg DC, Spears GF: Oral contraceptives and risk of breast cancer. Int J Cancer 46: 366– 373, 1990. 72 Greenspan AR, Hatcher RA, Moore M, et al: The association of depot-medroxyprogesterone acetate and breast cancer. Contraception 21: 563– 569, 1980. 73 World Health Organization: Depot-medroxyprogesterone acetate (DMPA) and cancer: Memorandum from a WHO meeting. Bull WHO 64: 375– 382, 1986. 74 Hulka BS, Chambless LE, Deubner DC, Wilkinson WE: Breast cancer and estrogen replacement therapy. Am J Obstet Gynecol 143: 638– 644, 1982. 75 Buring JE, Hennekens CH, Lipnick RJ, et al: A prospective cohort study of postmenopausal hormone use and risk of breast cancer in US women. Am J Epidemiol 125: 939– 947, 1987. 76 Brinton LA, Hoover R, Fraumeni JF Jr: Menopausal oestrogens and breast cancer risk: An expanded case-control study. Br J Cancer 54: 825– 832, 1986. 77 Wingo PA, Layde PM, Lee NC, et al: The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. JAMA 257: 209– 215, 1987. 78 La Vecchia C, Decarli A, Parazzini F, et al: Non-contraceptive oestrogens and the risk of breast cancer in women. Int J Cancer 38: 853– 858, 1986. 79 Hiatt RA, Bawol R, Friedman GD, Hoover R: Exogenous estrogen and breast cancer after bilateral oophorectomy. Cancer 54: 139– 144, 1984. 80 Nomura AM, Kolonel LN, Hirohata T, Lee J: The association of replacement estrogens with breast cancer. Int J Cancer 37: 49– 53, 1986. 81 Hunt K, Vessey M, McPherson K, Coleman M: Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol 94: 620– 635, 1987. 82 Brinton LA, Hoover RN, Szklo M, Fraumeni JF Jr: Menopausal estrogen use and risk of breast cancer. Cancer 47: 2517– 2522, 1981. 83 Ross RK, Paganini-Hill A, Gerkins VR, et al: A case-control study of menopausal estrogen therapy and breast cancer. JAMA 243: 1635– 1639, 1980. 83a Colditz GA, Stampfer MJ, Willett WC, et al: Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA 264: 2648– 2653, 1990. 84 Bergkvist L, Adami HO, Persson I, et al: The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321: 293– 297, 1989. 85 Beral V, Colwell L: Randomised trial of high doses of stilboestrol and ethisterone in pregnancy: Long-term follow-up of mothers. Br Med J 281: 1098– 1101, 1980. 86 Vessey MP, Fairweather DV, Norman-Smith B, Buckley J: A randomized double-blind controlled trial of the value of stilboestrol therapy in pregnancy: Long-term follow-up of mothers and their offspring. Br J Obstet Gynaecol 90: 1007– 1017, 1983. 87 Hadjimichael OC, Meigs JW, Falcier FW, et al: Cancer risk among women exposed to exogenous estrogens during pregnancy. J Natl Cancer Inst 73: 831– 834, 1984. 88 Greenberg ER, Barnes AB, Resseguie L, et al: Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med 311: 1393– 1398, 1984. 89 Lubin F, Ruder AM, Wax Y, Modan B: Overweight and changes in weight throughout adult life in breast cancer etiology: A case-control study. Am J Epidemiol 122: 579– 588, 1985. 90 Le Marchand L, Kolonel LN, Earle ME, Mi MP: Body size at different periods of life and breast cancer risk. Am J Epidemiol 128: 137– 152, 1988. 91 London SJ, Colditz GA, Stampfer MJ, et al: Prospective study of relative weight, height, and risk of breast cancer. JAMA 262: 2853– 2858, 1989. 92 Siiteri PK: Adipose tissue as a source of hormones. Am J Clin Nutr 45 (suppl 1): 277– 282, 1987. 93 Parazzini F, La Vecchia C, Negri E, et al: Anthropometric variables and risk of breast cancer. Int J Cancer 45: 397– 402, 1990. 94 Folsom AR, Kaye SA, Prineas RJ, et al: Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 131: 794– 803, 1990. 95 Ballard-Barbash R, Schatzkin A, Carter CL, et al: Body fat distribution and breast cancer in the Framingham study. J Natl Cancer Inst 82: 286– 290, 1990. 96 Lapidus L, Helgesson O, Merck C, Björntorp P: Adipose tissue distribution and female carcinomas: A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Int J Obes 12: 361– 368, 1988. 97 Swanson CA, Jones DY, Schatzkin A, et al: Breast cancer risk assessed by anthropometry in the NHANES I epidemiological follow-up study. Cancer Res 48: 5363– 5367, 1988. 98 Ip C, Ip MM: Serum estrogens and estrogen responsiveness in 7,12-dimethylbenz[a]anthracene-induced mammary tumors as influenced by dietary fat. J Natl Cancer Inst 66: 291– 295, 1981. 99 Armstrong B, Doll R: Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15: 617– 631, 1975. 100 Miller AB: Role of nutrition in the etiology of breast cancer. Cancer 39 (suppl 6): 2704– 2708, 1977. 101 Willett WC, Stampfer MJ, Colditz GA, et al: Dietary fat and the risk of breast cancer. N Engl J Med 316: 22– 28, 1987. 102 Graham S, Marshall J, Mettlin C, et al: Diet in the epidemiology of breast cancer. Am J Epidemiol 116: 68– 75, 1982. 103 Hirohata T, Nomura AM, Hankin JH, et al: An epidemiologic study on the association between diet and breast cancer. J Natl Cancer Inst 78: 595– 600, 1987. 104 Jones DY, Schatzkin A, Green SB, et al: Dietary fat and breast cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. J Natl Cancer Inst 79: 465– 471, 1987. 105 Katsouyanni K, Willett W, Trichopoulos D, et al: Risk of breast cancer among Greek women in relation to nutrient intake. Cancer 61: 181– 185, 1988. 106 Schatzkin A, Hoover RN, Taylor PR, et al: Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Cancer Res 48: 452– 458, 1988. 107 La Vecchia C, Decarli A, Franceschi S, et al: Dietary factors and the risk of breast cancer. Nutr Cancer 10: 205– 214, 1987. 108 Pryor M, Slattery ML, Robison LM, Egger M: Adolescent diet and breast cancer in Utah. Cancer Res 49: 2161– 2167, 1989. 109 Rohan TE, McMichael AJ, Baghurst PA: A population-based case-control study of diet and breast cancer in Australia. Am J Epidemiol 128: 478– 489, 1988. 110 Mills PK, Beeson WL, Phillips RL, Fraser GE: Dietary habits and breast cancer incidence among Seventh-day Adventists. Cancer 64: 582– 590, 1989. 111 Ursin G, Bjelke E, Heuch I, Vollset SE: Milk consumption and cancer incidence: A Norwegian prospective study. Br J Cancer 61: 456– 459, 1990. 112 Katsouyanni K, Trichopoulos D, Boyle P, et al: Diet and breast cancer: A case-control study in Greece. Int J Cancer 38: 815– 820, 1986. 113 Adlercreutz H, Fotsis T, Bannwart C, et al: Urinary estrogen profile determination in young Finnish vegetarian and omnivorous women. J Steroid Biochem 24: 289– 296, 1986. 114 Rose DP, Boyar AP, Cohen C, Strong LE: Effect of a low-fat diet on hormone levels in women with cystic breast disease: I. Serum steroid and gonadotropins. J Natl Cancer Inst 78: 623– 626, 1987. 115 Goldin BR, Adlercreutz H, Gorbach SL, et al: Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med 307: 1542– 1547, 1982. 116 Rose DP, Cohen LA, Berke B, Boyar AP: Effect of a low-fat diet on hormone levels in women with cystic breast disease: II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones. J Natl Cancer Inst 78: 627– 631, 1987. 117 Prentice R, Thompson D, Clifford C, et al: Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. J Natl Cancer Inst 82: 129– 134, 1990. 118 Marubini E, Decarli A, Costa A, et al: The relationship of dietary intake and serum levels of retinol and beta-carotene with breast cancer: Results of a case-control study. Cancer 61: 173– 180, 1988. 119 Russell MJ, Thomas BS, Bulbrook RD: A prospective study of the relationship between serum vitamins A and E and risk of breast cancer. Br J Cancer 57: 213– 215, 1988. 120 Wald NJ, Boreham J, Haywood JL, Bulbrook RD: Plasma retinol, beta-carotene and vitamin E levels in relation to the future risk of breast cancer. Br J Cancer 49: 321– 324, 1984. 121 Peleg I, Heyden S, Knowles M, Hames CG: Serum retinol and risk of subsequent cancer: Extension of the Evans County, Georgia, study. J Natl Cancer Inst 73: 1455– 1458, 1984. 121a Michnovicz JJ, Bradlow HL: Induction of estradiol metabolism by dietary indole-3-carbinol in humans. J Natl Cancer Inst 82: 947– 949, 1990. 122 van Noord PA, Collette HJ, Maas MJ, de Waard F: Selenium levels in nails of premenopausal breast cancer patients assessed pre-diagnostically in a cohort-nested case-referent study among women screened in the DOM project. Int J Epidemiol 16: 318– 322, 1987. 123 Meyer F, Verreault R: Erythrocyte selenium and breast cancer risk. Am J Epidemiol 125: 917– 919, 1987. 124 Thompson HJ, Becci PJ: Selenium inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis in the rat. J Natl Cancer Inst 65: 1299– 1301, 1980. 125 Rohan TE, Bain CJ: Diet in the etiology of breast cancer. Epidemiol Rev 9: 120– 145, 1987. 126 Iscovich JM, Iscovich RB, Howe G, et al: A case-control study of diet and breast cancer in Argentina. Int J Cancer 44: 770– 776, 1989. 127 Walker BE: Tumors in female offspring of control and diethylstilbestrol-exposed mice fed high-fat diets. J Natl Cancer Inst 82: 50– 54, 1990. 128 Willett W: The search for the causes of breast and colon cancer. Nature 338: 389– 394, 1989. 129 Hiatt RA, Bawol RD: Alcoholic beverage consumption and breast cancer incidence. Am J Epidemiol 120: 676– 683, 1984. 130 Harvey EB, Schairer C, Brinton LA, et al: Alcohol consumption and breast cancer. J Natl Cancer Inst 78: 657– 661, 1987. 131 O'Connell DL, Hulka BS, Chambless LE, et al: Cigarette smoking, alcohol consumption, and breast cancer risk. J Natl Cancer Inst 78: 229– 234, 1987. 132 Schatzkin A, Jones DY, Hoover RN, et al: Alcohol consumption and breast cancer in the epidemiologic follow-up study of the first National Health and Nutrition Examination Survey. N Engl J Med 316: 1169– 1173, 1987. 133 Willett WC, Stampfer MJ, Colditz GA, et al: Moderate alcohol consumption and the risk of breast cancer. N Engl J Med 316: 1174– 1180, 1987. 134 Rohan TE, McMichael AJ: Alcohol consumption and risk of breast cancer. Int J Cancer 41: 695– 699, 1988. 135 Toniolo P, Riboli E, Protta F, et al: Breast cancer and alcohol consumption: A case-control study in northern Italy. Cancer Res 49: 5203– 5206, 1989. 136 Young TB: A case-control study of breast cancer and alcohol consumption habits. Cancer 64: 552– 558, 1989. 137 Adami HO, Lund E, Bergström R, Meirik O: Cigarette smoking, alcohol consumption and risk of breast cancer in young women. Br J Cancer 58: 832– 837, 1988. 138 Harris RE, Wynder EL: Breast cancer and alcohol consumption: A study in weak associations. JAMA 259: 2867– 2871, 1988. 139 Chu SY, Lee NC, Wingo PA, Webster LA: Alcohol consumption and the risk of breast cancer. Am J Epidemiol 130: 867– 877, 1989. 140 Meara J, McPherson K, Roberts M, et al: Alcohol, cigarette smoking and breast cancer. Br J Cancer 60: 70– 73, 1989. 141 Schatzkin A, Carter CL, Green SB, et al: Is alcohol consumption related to breast cancer? Results from the Framingham Heart Study. J Natl Cancer Inst 81: 31– 35, 1989. 142 Rosenberg L, Palmer JR, Miller DR, et al: A case-control study of alcoholic beverage consumption and breast cancer. Am J Epidemiol 131: 6– 14, 1990. 143 Longnecker MP, Berlin JA, Orza MJ, Chalmers TC: A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA 260: 652– 656, 1988. 144 Lowenfels AB: Comments on meta-analysis (letter). Am J Public Health 79: 102– 103, 1989. 145 Rosenberg L: Meta-analysis of alcohol and risk of breast cancer (letter). JAMA 261: 383, 1989. 146 Freund G: Possible relationships of alcohol in membranes to cancer. Cancer Res 39: 2899– 2901, 1979. 147 Wickramasinghe SN, Gardner B, Barden G: Cytotoxic protein molecules generated as a consequence of ethanol metabolism in vitro and in vivo. Lancet 2: 823– 826, 1986. 148 Lieber CS, Seitz HK, Garro AJ, Worner TM: Alcohol-related diseases and carcinogenesis. Cancer Res 39 (7 Pt 2): 2863– 2886, 1979. 149 Swann PF, Coe AM, Mace R: Ethanol and dimethylnitrosamine and diethylnitrosamine metabolism and disposition in the rat: Possible relevance to the influence of ethanol on human cancer incidence. Carcinogenesis 5: 1337– 1343, 1984. 150 Lawson DH, Jick H, Rothman KJ: Coffee and tea consumption and breast disease. Surgery 90: 801– 803, 1981. 151 Lubin F, Ron E, Wax Y, Modan B: Coffee and methylxanthines and breast cancer: A case-control study. J Natl Cancer Inst 74: 569– 573, 1985. 152 Schairer C, Brinton LA, Hoover RN: Methylxanthines and breast cancer. Int J Cancer 40: 469– 473, 1987. 153 Rohan TE, McMichael AJ: Methylxanthines and breast cancer. Int J Cancer 41: 390– 393, 1988. 154 Baron JA: Smoking and estrogen-related disease. Am J Epidemiol 119: 9– 22, 1984. 155 Baron JA, Byers T, Greenberg ER, et al: Cigarette smoking in women with cancers of the breast and reproductive organs. J Natl Cancer Inst 77: 677– 680, 1986. 156 London SJ, Colditz GA, Stampfer MJ, et al: Prospective study of smoking and the risk of breast cancer. J Natl Cancer Inst 81: 1625– 1631, 1989. 157 Rohan TE, Baron JA: Cigarette smoking and breast cancer. Am J Epidemiol 129: 36– 42, 1989. 158 Kaufman DW, Werler MM, Palmer JR, et al: Diazepam use in relation to breast cancer: Results from two case-control studies. Am J Epidemiol 131: 483– 490, 1990. 159 Frisch RE, Wyshak G, Albright NL, et al: Lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to non-athletes. Br J Cancer 52: 885– 891, 1985. 160 Albanes D, Blair A, Taylor PR: Physical activity and risk of cancer in the NHANES I population. Am J Public Health 79: 744– 750, 1989. 161 Bernstein L, Ross RK, Lobo RA, et al: The effects of moderate physical activity on menstrual cycle patterns in adolescence: Implications for breast cancer prevention. Br J Cancer 55: 681– 685, 1987. 162 Ellison PT, Lager C: Moderate recreational running is associated with lowered salivary progesterone profiles in women. Am J Obstet Gynecol 154: 1000– 1003, 1986. 163 Fisher EC, Nelson ME, Frontera WR, et al: Bone mineral content and levels of gonadotropins and estrogens in amenorrheic running women. J Clin Endocrinol Metab 62: 1232– 1236, 1986. 164 Stevens RG: Electric power use and breast cancer: A hypothesis. Am J Epidemiol 125: 556– 561, 1987. 165 Wertheimer N, Leeper E: Magnetic field exposure related to cancer subtypes. Ann NY Acad Sci 502: 43– 54, 1987. 166 McDowall ME: Mortality of persons resident in the vicinity of electricity transmission facilities. Br J Cancer 53: 271– 279, 1986. 167 Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312: 146– 151, 1985. 168 Dupont WD, Page DL: Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol 125: 769– 779, 1987. 169 Hutchinson WB, Thomas DB, Hamlin WB, et al: Risk of breast cancer in women with benign breast disease. J Natl Cancer Inst 65: 13– 20, 1980. 170 Moskowitz M, Gartside P, Wirman JA, McLaughlin C: Proliferative disorders of the breast as risk factors for breast cancer in a self-selected screened population: Pathologic markers. Radiology 134: 289– 291, 1980. 171 Consensus Meeting: Is " fibrocystic disease" of the breast precancerous?. Arch Pathol Lab Med 110: 171– 173, 1986. 172 Jensen RA, Page DL, Dupont WD, Rogers LW: Invasive breast cancer risk in women with sclerosing adenosis. Cancer 64: 1977– 1983, 1989. 173 Wolfe JN: Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol 126: 1130– 1137, 1976. 174 Wolfe JN: Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 37: 2486– 2492, 1976. 175 Saftlas AF, Szklo M: Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev 9: 146– 174, 1987. 176 Goodwin PJ, Boyd NF: Mammographic parenchymal pattern and breast cancer risk: A critical appraisal of the evidence. Am J Epidemiol 127: 1097– 1108, 1988. 177 Harvey EB, Brinton LA: Second cancer following cancer of the breast in Connecticut, 1935–82. NCI Monogr 68: 99– 112, 1985. 178 Fisher ER, Fisher B, Sass R, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no 4): XL. Bilateral breast cancer. Cancer 54: 3002– 3011, 1984. 179 Anderson DE, Badzioch MD: Bilaterality in familial breast cancer patients. Cancer 56: 2092– 2098, 1985. 180 Horn PL, Thompson WD: Risk of contralateral breast cancer: Associations with factors related to initial breast cancer. Am J Epidemiol 128: 309– 323, 1988. 181 Hankey BF, Curtis RE, Naughton MD, et al: A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. J Natl Cancer Inst 70: 797– 804, 1983. 182 Burns PE, Dabbs K, May C, et al: Bilateral breast cancer in northern Alberta: Risk factors and survival patterns. Can Med Assoc J 130: 881– 886, 1984. 183 Hislop TG, Elwood JM, Coldman AJ, et al: Second primary cancers of the breast: Incidence and risk factors. Br J Cancer 49: 79– 85, 1984. 184 Horn PL, Thompson WD: Risk of contralateral breast cancer: Associations with histologic, clinical, and therapeutic factors. Cancer 62: 412– 424, 1988. 185 Curtis RE, Hoover RN, Kleinerman RA, Harvey EB: Second cancer following cancer of the female genital system in Connecticut, 1935–82. NCI Monogr 68: 113– 137, 1985. 186 Sattin RW, Rubin GL, Webster LA, et al: Family history and the risk of breast cancer. JAMA 253: 1908– 1913, 1985. 187 Anderson DE, Badzioch MD: Risk of familial breast cancer. Cancer 56: 383– 387, 1985. 188 Ottman R, Pike MC, King MC, Henderson BE: Practical guide for estimating risk for familial breast cancer. Lancet 2: 556– 558, 1983. 189 Ottman R, Pike MC, King MC, et al: Familial breast cancer in a population-based series. Am J Epidemiol 123: 15– 21, 1986. 190 Schwartz AG, King MC, Belle SH, et al: Risk of breast cancer to relatives of young breast cancer patients. J Natl Cancer Inst 75: 665– 668, 1985. 191 Swift M, Reitnauer PJ, Morrell D, et al: Breast and other cancers in families with ataxiatelangiectasia. N Engl J Med 316: 1289– 1294, 1987. 192 Newman B, Austin MA, Lee M, King MC: Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 85: 3044– 3048, 1988. 193 Stanford JL, Szklo M, Brinton LA: Estrogen receptors and breast cancer. Epidemiol Rev 8: 42– 59, 1986. 194 Land CE, Boice JD Jr, Shore RE, et al: Breast cancer risk from low-dose exposures to ionizing radiation: Results of parallel analysis of three exposed populations of women. J Natl Cancer Inst 65: 353– 376, 1980. 195 Boice JD Jr, Land CE, Shore RE, et al: Risk of breast cancer following low-dose radiation exposure. Radiology 131: 589– 597, 1979. 196 Hrubec Z, Boice JD Jr, Monson RR, Rosenstein M: Breast cancer after multiple chest fluoroscopies: Second follow-up of Massachusetts women with tuberculosis. Cancer Res 49: 229– 234, 1989. 197 Miller AB, Howe GR, Sherman GJ, et al: Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 321: 1285– 1289, 1989. 198 Tokunaga M, Land CE, Yamamoto T, et al: Breast cancer in Japanese A-bomb survivors (letter). Lancet 2: 924, 1982. 199 Modan B, Chetrit A, Alfandary E, Katz L: Increased risk of breast cancer after low-dose irradiation. Lancet 1: 629– 631, 1989. 200 Hoffman DA, Lonstein JE, Morin MM, et al: Breast cancer in women with scoliosis exposed to multiple diagnostic x-rays. J Natl Cancer Inst 81: 1307– 1312, 1989. 201 Hildreth NG, Shore RE, Hempelmann LH, Rosenstein M: Risk of extrathyroid tumors following radiation treatment in infancy for thymic enlargement. Radiat Res 102: 378– 391, 1985. 202 Hildreth NG, Shore RE, Dvoretsky PM: The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 321: 1281– 1284, 1989. 203 Evans JS, Wennberg JE, McNeil BJ: The influence of diagnostic radiography on the incidence of breast cancer and leukemia. N Engl J Med 315: 810– 815, 1986. 204 Boice JD Jr, Blettner M, Kleinerman RA, et al: Radiation dose and breast cancer risk in patients treated for cancer of the cervix. Int J Cancer 44: 7– 16, 1989. 205 Kelsey JL: A review of the epidemiology of human breast cancer. Epidemiol Rev 1: 74– 109, 1979. 206 Kelsey JL, Gammon MD: Update: Epidemiology of breast cancer. Epidemiol Rev 12: 228– 240, 1990. 207 Kelsey JL, Berkowitz GS: Breast cancer epidemiology. Cancer Res 48: 5615– 5623, 1988. 208 Gammon MD: Infertility and Breast Cancer: A Population-Based Case-Control Study. PhD dissertation, Yale University, 1989. Citing Literature Volume41, Issue3May/June 1991Pages 146-165 ReferencesRelatedInformation
Referência(s)